preservision-eye-vitamins-areds-2

The FIRST and ONLY supplement that exactly matches the updated National Eye Institute recommended nutrient formula based on evidence from the 2013 AREDS2 Study.

In May of 2013, the NEI proposed a modification to the original AREDS formula as follows:

  • Removing beta-carotene
  • Adding 10 mg lutein and 2 mg zeaxanthin (per day)
  • Leaving the 80 mg zinc dose unchanged from the original AREDS formula

PreserVision Eye Vitamin AREDS 2 Formula builds on the original, clinically proven PreserVision AREDS Formula, with lutein and zeaxanthin replacing beta-carotene based on the AREDS2 study.*

Completed in 2013, the Age Related Eye Disease Study 2 (AREDS2) was a 5-year study conducted by the National Eye Institute (NEI) of the National Institutes of Health. For more information from the National Eye Institute on the Age-Related Eye Disease Study and AREDS2, click here.

Key Features & Benefits

  • Contains the exact same levels of all six clinically proven nutrients now recommended by the NEI based on the clinical evidence from the AREDS2 Study
  • Beta-carotene free
  • Patented formula – not available as a store brand
  • Now in 2 per day dosing
  • #1 Doctor recommended brand

Ingredients

Preservision AREDS2 Eye Vitamins Supplement Facts

Directions

Take 2 Soft Gels daily; 1 in the morning, 1 in the evening with food.

New! Preservision AREDS 2 Formula : Additional information


*The statements above have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

**Professional Samples are for eye care practitioners only. A qualified practitioner, for this program, is defined as one that is on a registered list compiled through the American Medical Association. Good only in USA. Samples are not for resale. Any other use constitutes fraud.

 

Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013 May 15;309(19):2005-15. National Eye Institute website: http://www.nei.nih.gov/areds2/ Accessed October 2013. AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS).



US/PV2/13/0073